What systemic therapy would you offer to a patient with metastatic EGFR exon 19 deleted NSCLC to the brain with isolated CNS progression while on osimertinib 80 mg and progressed through WBRT?  

Do you consider dose escalating to 160 mg or do you add chemotherapy to osimertinib?

Answer from: Medical Oncologist at Academic Institution